PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: GTCbio - Biopharmaceutical Conference

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Pradeep Nathan, Director of Neuroscience, GSK Featured at Neuro Biomarkers Meeting, September 6th-7th in Zurich - Pradeep Nathan, Director of Neuroscience at GlaxoSmithKline will give a featured presentation on ‘What is the Value of Functional Imaging in Early Clinical Development?’ at GTC’s Neurological Biomarkers conference
Pradeep Nathan, Director of Neuroscience, GSK Featured at Neuro Biomarkers Meeting, September 6th-7th in Zurich

 

NewswireToday - /newswire/ - Zurich, Switzerland, 2012/07/25 - Pradeep Nathan, Director of Neuroscience at GlaxoSmithKline will give a featured presentation on ‘What is the Value of Functional Imaging in Early Clinical Development?’ at GTC’s Neurological Biomarkers conference.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Pradeep Nathan, Director of Neuroscience at GlaxoSmithKline will give a featured presentation on ‘What is the Value of Functional Imaging in Early Clinical Development?’ at GTC’s Neurological Biomarkers conference (Sept 6th-7th, 2012 in, Switzerland)

Functional Imaging is being increasingly used in early clinical development to answer questions related to target engagement, differential efficacy and relationship with clinical outcome. However, the value of functional imaging is yet to be fully appreciated. Dr. Nathan will give examples of studies that have been done at GSK. fMRI has been used to address early clinical development questions. Dr. Nathan will outline where there is promise and where there are limitations for fMRI as a biomarker.

Professor Pradeep Nathan holds a joint appointment as Director of Neuroscience and Experimental Medicine at GlaxoSmithKline Pharmaceuticals and Lecturer in the Department of Psychiatry at Cambridge University. He is also an Adjunct Professor in the School of Psychology and Psychiatry at Monash University. Professor Nathan’s research is primarily focused on the development of translational and biological markers of neurological and psychiatric disorders, neurochemical basis of cognitive function and drug discovery. He has published over 130 peer reviewed papers and has contributed to the pre-clinical and early clinical development of a number of new drug candidates for addiction, schizophrenia, Huntington’s disease, and Alzheimer’s disease.

GTC’s Neurological Biomarkers conference is part of the 2nd Biomarkers Europe Summit and will bring together leading experts across the industry and academia to discuss the latest research and developments in the biomarker field. Other tracks of the summit include:

5th Oncology Biomarkers (Sept. 5th – 7th) | Inflammatory Biomarkers (Sept. 6th – 7th)

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: GTCbio - Biopharmaceutical Conference

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Pradeep Nathan, Director of Neuroscience, GSK Featured at Neuro Biomarkers Meeting, September 6th-7th in Zurich

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: GTCbio.com 
626-256-6405 may.lee[.]gtcbio.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GTCbio - Biopharmaceutical Conference securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From GTCbio - Biopharmaceutical Conference / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Veritor™ System Meets FDA’s New Performance Requirements for Rapid Influenza Antigen Detection Tests
Sub-Sahara Africa - Increase in Western Lifestyles Leads to Dire Need for Chronic Prescription Drugs Finds Frost & Sullivan
BD Initiates New Industry Alliance to Combat Rising Opioid Crisis
BTG and Society of Interventional Oncology to Explore Role of Minimally Invasive Therapies in Immuno-oncology
Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi
BD Announces Early Access Program for BD Resolve™ Single-Cell Analysis Platform
Precision Medicine Unlocks the Future of Targeted Therapy in the Global Healthcare Industry Finds Frost & Sullivan
Sciformix Corporation Receives Prestigious 2017 Global Outsourcing Customer Service Leadership Award from Frost & Sullivan
Arven Pharmaceuticals Selects GE Healthcare’s FlexFactory to Improve Turkish and Regional Access to Biopharmaceuticals
Ipsen to Acquire Primary Care Platform in Italy from Akkadeas Pharma
Cost-Containment and Client-Centric Services Catalyse European Custom Procedure Trays and Packs Market Finds Frost & Sullivan
New BD Institute for Medication Management Excellence Aims to Improve Patient Safety and Outcomes through Collaboration
New Varicose Vein Treatment Offers Minimally Invasive Non Surgical Procedure to Canadians
Greenphire and Exostar Partner to Deliver Seamless, Secure Access to Clinical Research Site Payment Solution
PleurX™ Catheter System Receives FDA 510(k) Clearance for Specific Non-Malignant Recurrent Pleural Effusions

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  NAKIVO, Inc.

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)